Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:393-398
doi: 10.1161/hc2901.093115
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sesso, H. D.
Right arrow Articles by Buring, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sesso, H. D.
Right arrow Articles by Buring, J. E.
Related Collections
Right arrow Epidemiology
Right arrow Cerebrovascular disease/stroke
Right arrow Genetics of cardiovascular disease
Right arrow Primary prevention
Right arrow Risk Factors for Stroke

(Circulation. 2001;104:393.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Maternal and Paternal History of Myocardial Infarction and Risk of Cardiovascular Disease in Men and Women

Howard D. Sesso, ScD, MPH; I-Min Lee, MBBS, ScD; J. Michael Gaziano, MD, MPH; Kathryn M. Rexrode, MD, MPH; Robert J. Glynn, ScD; Julie E. Buring, ScD

From the Division of Preventive Medicine (H.D.S., I.-M.L., J.M.G., K.M.R., R.J.G., J.E.B.), Brigham and Women’s Hospital, Boston, Mass; Department of Epidemiology (H.D.S., I.-M.L., J.M.G., J.E.B.) and Department of Biostatistics (R.J.G.), Harvard School of Public Health, Boston, Mass; Massachusetts Veterans Epidemiology Research and Information Center (H.D.S., J.M.G.), Veterans Affairs Medical Center, Boston, Mass; and Department of Ambulatory Care and Prevention (J.E.B.), Harvard Medical School, Boston, Mass.

Correspondence to Howard D. Sesso, Brigham and Women’s Hospital, 900 Commonwealth Ave E, Boston, MA 02215-1204. E-mail hsesso{at}hsph.harvard.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— Few studies have examined the effects of paternal and maternal history of myocardial infarction (MI), including age at MI, on cardiovascular disease (CVD) risk, particularly among women.

Methods and Results— We prospectively studied 22 071 men from the Physicians’ Health Study and 39 876 women from the Women’s Health Study with data on parental history and age at MI. Among men, 2654 CVD cases developed over 13.0 years; among women, 563 CVD cases occurred over 6.2 years. Compared with men with no parental history, only maternal, only paternal, and both maternal and paternal history of MI conferred relative risks (RRs) of CVD of 1.71, 1.40, and 1.85; among women, the respective RRs were 1.46, 1.15, and 2.05. For men, maternal age at MI of <50, 50 to 59, 60 to 69, 70 to 79, and >=80 years had RRs of 1.00, 1.88, 1.88, 1.67, and 1.17; for women, the RRs for maternal age at MI of <50, 50 to 59, and >=60 years were 2.57, 1.33, and 1.52. Paternal age at MI of <50, 50 to 59, 60 to 69, 70 to 79, and >=80 years in men had RRs of 2.19, 1.64, 1.42, 1.16, and 0.92; in women, for paternal age at MI of <50, 50 to 59, and >=60 years, the RRs were 1.63, 1.33, and 1.13.

Conclusions— An early history of parental MI (<60 years) conferred a greater risk of CVD than did MI at older ages. However, an increased risk of CVD remained for maternal age at MI of 70 to 79 years in men and >=60 years in women, which suggests that any maternal history of MI may be important.


Key Words: myocardial infarction • risk factors • cardiovascular diseases • epidemiology • prevention


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Epidemiological studies indicate that a parental or family history of myocardial infarction (MI) is an independent risk factor for cardiovascular disease (CVD).1 Parental history of MI is often considered a surrogate for coronary risk factors, having associations with high blood pressure, poor lipid profiles, and obesity in children2 and adults,3 as well as other biochemical and genetic markers.46 Limited epidemiological evidence exists in women regarding the association between parental history of MI and CVD risk. Moreover, various definitions of parental history of MI in the existing literature7 neglect the separate effects of paternal and maternal history and whether there are comparable effects on the risk of CVD. Definitions of early parental history before the age of 60 years likely underestimate the impact of maternal history of MI because of the low incidence rates of MI in women before age 60.8

Therefore, we examined the association of parental history of MI and risk of CVD in 2 large prospective cohorts of men and women. The separate effects of paternal and maternal history of MI on CVD risk were examined, as well as the effect of age of parental MI and CVD risk.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Study Populations
The Physicians’ Health Study (PHS) is a completed trial of aspirin and beta-carotene in the primary prevention of CVD and cancer.9 Briefly, 22 071 US male physicians aged 40 to 84 years and free from prior MI, stroke, transient ischemic attack, and cancer (except nonmelanoma skin cancer) were enrolled in 1982. The Women’s Health Study (WHS) is an ongoing trial of aspirin and vitamin E in the primary prevention of CVD and cancer.10 A total of 39 876 female US health professionals aged >=45 years, postmenopausal or not intending to become pregnant and free from similar diseases as subjects in the PHS, were enrolled in 1992.

Data Collection
Men provided self-reports of baseline coronary risk factors, including age, smoking habit, alcohol, vigorous exercise, hypertension, and diabetes mellitus. Body mass index (BMI; in kg/m2) was calculated from height and weight. Women provided baseline information on the above variables plus postmenopausal status and postmenopausal hormone use.

On the PHS 12-month follow-up questionnaire, men responding yes to either "Has your mother ever had a documented MI?" or "Has your father ever had a documented MI?" provided the age of the parent at that MI. At baseline in the WHS, women were asked "Did any of these relatives ever have an MI," including their mother or father, plus the age category (<40 years, 40 to 49, 50 to 59, >=60, or unknown) of that MI. Parental history of MI was classified as none, maternal only, paternal only, or both. In the PHS, age at MI was categorized as none, <50, 50 to 59, 60 to 69, 70 to 79, and >=80 years; in the WHS, age was classified as none, <50, 50 to 59, and >=60 years.

Among the 22 071 randomized men in PHS, subjects were excluded if they had missing data on parental history of MI or had prerandomization angina, CABG, or PTCA. These exclusions resulted in a study population of 20 515 men. Similar exclusions in the WHS reduced the study population from 39 876 to 37 985 women.

Outcome Ascertainment
Follow-up in PHS consisted of annual questionnaires on which participants reported CVD events (MI, CABG, PTCA, stroke, or cardiovascular death) since the last questionnaire. Medical records were obtained and reviewed by an independent committee of physicians for reports of MI or stroke. MI was confirmed with World Health Organization criteria.11 Stroke was defined as a typical neurological deficit, sudden or rapid in onset, lasting >24 hours. CVD death was documented by convincing evidence of a cardiovascular mechanism from death certificates and medical records. All analyses are based on the first confirmed CVD event. After a median follow-up of 13.0 years (maximum follow-up, 14.4 years), morbidity and mortality follow-up rates were 99.2% and 99.99% complete.9

Follow-up in WHS was accomplished by similar methods and annual follow-up questionnaires. Total CVD was defined in WHS in a manner similar to that in the PHS but with CABG and PTCA also confirmed by hospital records. After a median follow-up of 6.0 years (maximum follow-up 6.9 years), morbidity and mortality follow-up rates were 98.9% and 99.9% complete.

Data Analyses
Separate analyses were done for men and women. Participants were first examined by categories of parental history with ANCOVA to compare mean values or {chi}2 tests to compare proportions of baseline coronary risk factors. Cox proportional hazards models estimated the relative risk (RR) and 95% CI of CVD, MI, and stroke. Three separate sets of models were fitted for parental history of MI, age of maternal MI, and age of paternal MI. We first examined crude models, then added age, and then further adjusted for BMI, smoking status, exercise, and alcohol intake. Additional covariates in models for men included randomized aspirin and beta-carotene treatment; for women, randomized aspirin and vitamin E treatment, postmenopausal status, and postmenopausal hormone use were included. In secondary analyses, we examined whether variables potentially on the causal pathway (hypertension, blood pressure, and diabetes) altered the findings. The parameter estimates of maternal versus paternal history of MI were compared by the inclusion of terms for maternal age of MI (mean centered), maternal history, paternal age of MI (mean centered), and paternal history in a multivariate model. Likelihood ratio tests compared models with maternal, paternal, and both maternal and paternal history of MI.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
The proportions of men with no parental history of MI, only a maternal history, only a paternal history, or a history in both parents were 65.5%, 5.6%, 25.3%, and 3.5%, respectively; for women, the respective proportions were 65.9%, 7.9%, 21.8%, and 4.4%. Table 1 compares baseline characteristics of men and women according to parental history of MI. Statistically significant differences in age and history of hypertension by category of parental history of MI were found for both men and women, whereas significant differences in diabetes, smoking, exercise, and alcohol were found for either men or women.


View this table:
[in this window]
[in a new window]
 
Table 1. Baseline Characteristics According to Categories of Parental History of MI at Baseline

There were 2654 CVD events (including 653 MI cases and 613 stroke cases) in men and 563 CVD events (including 159 MI cases and 195 stroke cases) in women during follow-up. We examined the effect of parental history on the risk of total CVD, MI, and stroke (Table 2). The addition of hypertension, diabetes, and blood pressure resulted in similar RRs (data not shown). The higher magnitude of RRs for maternal versus paternal history of MI was significantly different in men (P=0.01) but not women (P=0.13). Considering CVD subtypes, maternal history of MI was strongly associated with risk of MI (both P<0.05) but not stroke (both P>0.05) in men and women.


View this table:
[in this window]
[in a new window]
 
Table 2. Maternal and Paternal History of MI and RR (95% CI) of Total CVD, MI, and Stroke

We next examined the effect of maternal age at MI (Table 3). A total of 9.6% of women reported a maternal history with a maternal age of <50 years compared with only 2.2% of men. In men, even a maternal age at MI of 70 to 79 years was associated with a significant 67% increased risk of CVD (test for negative linear trend in maternal age, P=0.02). When stratified by paternal history of MI, men with no paternal history had a similar pattern to the overall RRs except that the significant increased risk of CVD extended through an age at maternal MI of >=80 years. Women with a maternal age at MI >=60 years also had a significant multivariate RR of 1.52, which suggests that history of maternal MI may be important regardless of maternal age at MI(test for negative linear trend in maternal age, P=0.16). In a model stratified by paternal history of MI, the association between maternal age at MI and risk of CVD closely approximated the overall results among women with no paternal history.


View this table:
[in this window]
[in a new window]
 
Effect of Age of Maternal MI and the RR (95% CI) of CVD, as Well as Its Joint Association With Paternal History of MI*

We next considered the effect of paternal age at MI on CVD risk (Table 4). A greater proportion of women with a paternal history of MI reported a younger (<50 years) paternal age at MI than did men (16.4% for women, 9.6% for men). Compared with men with no paternal history of MI, younger paternal ages at MI conferred greater magnitudes of CVD risk that decreased as paternal age increased (test for negative linear trend in paternal age, P<0.001). However, a paternal age at MI of 70 to 79 years was still associated with a small, significantly increased risk of CVD. Women with a paternal age at MI >=60 years had no increased risk of CVD (test for negative linear trend in paternal age, P=0.04). In a model stratified by maternal history of MI, the association between paternal age at MI and risk of CVD weakened among women with no maternal history. Still, women with both a paternal age at MI of <60 years and maternal age at MI of >=60 years had an RR of CVD of 3.68 (2.29 to 5.93; data not shown).


View this table:
[in this window]
[in a new window]
 
Effect of Age of Paternal MI and the RR (95% CI) of CVD, as Well as Its Joint Association With Maternal History of MI*

Other analytic issues were considered. First, multivariate models simultaneously included maternal and paternal age at MI and maternal and paternal history and found no difference between maternal and paternal history of MI and CVD in men (P=0.09) or women (P=0.89). The negative slopes for maternal and paternal age were marginally different in men (P=0.048) but similar in women (P=0.85). A model with both maternal and paternal history of MI added information beyond maternal history alone (men, P<0.05; women, P=0.06) and paternal history alone (men and women, P<0.05). We addressed potential survival bias by stratifying results by age dichotomized at 60 years. The RRs associated with maternal or paternal history of MI increased in magnitude among all subjects aged <60 years, with the exception of no differences for maternal history of MI when younger versus older men were compared (data not shown).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
These data confirm previous findings for an independent effect of parental history of MI on the risk of CVD. However, a maternal history of MI may be more strongly associated with risk of CVD than a paternal history of MI, primarily owing to its association with MI. Our study reinforces the notion that a premature (younger than 60 years of age) history of paternal MI confers a greater risk of CVD than does MI at older ages. However, maternal age at MI continued to confer a significantly increased risk of CVD for maternal ages as great as 70 to 79 years for men and >=60 years for women. These differences in risk for paternal versus maternal age at MI may simply reflect the inherent differences in incidence rates of MI for men and women.

A positive family history of MI is usually interpreted as early family history. The National Cholesterol Education Program defines a positive history as having a close blood relative with an MI younger than 55 years (father or brother) or younger than 65 years (mother or sister).12 Epidemiological studies embrace numerous similar definitions, commonly assuming that a positive parental history of MI occurs before age 60 years.13 However, on the basis of our data, a parental history of MI beyond age 60 still strongly predicts risk of CVD. This finding may be more important for maternal history of MI, because few women younger than 60 years of age have MIs.8 This may explain the higher risk of MI for older ages of maternal versus paternal MI. Thus, the more meaningful comparison may be to compare RRs for maternal age at MI versus paternal age at MI that is a decade younger. However, among men, we found that the decrease in magnitude of RRs across ages of parental MI was greater for paternal versus maternal history of MI. Furthermore, a greater magnitude of risk for MI persisted across a wider range of maternal ages. Therefore, any maternal history of MI, regardless of age at the event, may provide clinically relevant information in the assessment of CVD risk.

Parental history of MI reflects the genetic, biochemical, and behavioral components whereby an individual may be predisposed to be at higher risk of CVD. The present study is consistent with others1,14,1721 that support an independent effect of parental history of MI with CVD. Family history of MI affects lipids,22 inflammatory markers,23 and hemostatic markers.6 Higher RRs for maternal versus paternal history of MI may reflect phenotypic evidence that birth weight affects subsequent hypertension,24 diabetes,25 and insulin resistance syndrome.26 Alternatively, mothers may have greater influences on their children’s dietary and behavioral patterns retained later in life. No study has incorporated the entire array of genetic, biochemical, and behavioral risk factors to examine the extent to which the independent effects on CVD would be attenuated.

These findings must be considered in the context of some potential limitations. First, questions on the age of parental MI in the WHS had an upper category of >=60 years. It remains unclear whether the strong magnitude of effect for older ages of maternal MI in men extends to women. History of MI in other first-degree relatives (eg, siblings) or family history of other cardiovascular outcomes was not assessed. Additional details on family history of MI may further improve the definition of a positive family history and efforts to target high-risk individuals for CVD risk.7

The magnitude of the RRs of CVD associated with parental history of MI tended to be greater for younger versus older men,1416 which suggests that younger individuals are more likely to manifest the deleterious consequences of a parental history of MI. Individuals aged in their 40s may have parents with impending MIs after the age of 70. Some misclassification is likely, because younger subjects free of parental history of MI may later develop a positive history. Premature death also prevents MI from becoming manifested. Because we neither updated information on parental history of MI nor ascertained parental age or mortality status, we likely underestimated our RRs. Such competing risks would nominally affect the RRs for earlier parental ages of MI, because all subjects would have parents, if alive, who contributed data to those categories.

The identification of individuals with a parental history of MI provides important information for the clinician by which to target primary prevention efforts. A premature paternal history of MI was an important, independent predictor of CVD in both men and women. In contrast, maternal history of MI follows a different age distribution because CVD predominantly occurs in older, postmenopausal women. In fact, maternal history of MI appears to predict CVD at least as strongly as paternal history, and at older ages of maternal MI. Therefore, any maternal history of MI may provide valuable clinical information, perhaps challenging the assumption that only an early maternal history of MI is important and warranting other studies.


*    Acknowledgments
 
This study was supported in part by research grants CA-34944, CA-47988, CA-40368, HL-26490, HL-34595, and HL-43851 from the National Institutes of Health, Bethesda, Md.

Received January 26, 2001; revision received May 1, 2001; accepted May 3, 2001.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Shea S, Ottman R, Gabrieli C, et al. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol. 1984; 4: 793–801.[Abstract]
  2. Crea F, Gaspardone A, Tomai F, et al. Risk factors in schoolchildren associated with a family history of unheralded myocardial infarction or uncomplicated stable angina in male relatives. J Am Coll Cardiol. 1994; 23: 1472–1478.[Abstract]
  3. Slattery ML, Schumacher MC, Hunt SC, et al. The associations between family history of coronary heart disease, physical activity, dietary intake and body size. Int J Sports Med. 1993; 14: 93–99.[Medline] [Order article via Infotrieve]
  4. Martin S, Elosua R, Covas MI, et al. Relationship of lipoprotein(a) levels to physical activity and family history of coronary heart disease. Am J Public Health. 1999; 89: 383–385.[Abstract/Free Full Text]
  5. Margaglione M, Cappucci G, Colaizzo D, et al. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol. 1998; 18: 152–156.[Abstract/Free Full Text]
  6. Pankow JS, Folsom AR, Province MA, et al. Family history of coronary heart disease and hemostatic variables in middle-aged adults: Atherosclerosis Risk in Communities Investigators and Family Heart Study Research Group. Thromb Haemost. 1997; 77: 87–93.[Medline] [Order article via Infotrieve]
  7. Silberberg JS, Wlodarczyk J, Fryer J, et al. Risk associated with various definitions of family history of coronary heart disease: the Newcastle Family History Study II. Am J Epidemiol. 1998; 147: 1133–1139.[Abstract/Free Full Text]
  8. American Heart Association. 1998 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 1997.
  9. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996; 334: 1145–1149.[Abstract/Free Full Text]
  10. Buring JE, Hennekens CH, for the Women’s Health Study Research Group. The Women’s Health Study: summary of the study design. J Myocardial Ischemia. 1992; 4: 27–29.
  11. World Health Organization. Ischaemic Heart Disease Registers: Report of the Fifth Working Group, Including a Second Revision of the Operating Protocol: Copenhagen, 26–29 April 1971. Copenhagen, Denmark: Regional Office for Europe, World Health Organization; 1971.
  12. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994; 89: 1333–1445.[Medline] [Order article via Infotrieve]
  13. Stampfer MJ, Hu FB, Manson JE, et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000; 343: 16–22.[Abstract/Free Full Text]
  14. Colditz GA, Rimm EB, Giovannucci E, et al. A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol. 1991; 67: 933–938.[Medline] [Order article via Infotrieve]
  15. Hunt SC, Williams RR, Barlow GK. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis. 1986; 39: 809–821.[Medline] [Order article via Infotrieve]
  16. Williams RR, Hunt SC, Heiss G, et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol. 2001; 87: 129–135.[Medline] [Order article via Infotrieve]
  17. Perkins KA. Family history of coronary heart disease: is it an independent risk factor? Am J Epidemiol. 1986; 124: 182–194.[Free Full Text]
  18. Barrett-Connor E, Khaw K. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation. 1984; 69: 1065–1069.[Abstract/Free Full Text]
  19. Hopkins PN, Williams RR, Kuida H, et al. Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol. 1988; 62: 703–707.[Medline] [Order article via Infotrieve]
  20. Myers RH, Kiely DK, Cupples LA, et al. Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J. 1990; 120: 963–969.[Medline] [Order article via Infotrieve]
  21. Colditz GA, Stampfer MJ, Willett WC, et al. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am J Epidemiol. 1986; 123: 48–58.[Abstract/Free Full Text]
  22. Hippe M, Vestbo J, Bjerg AM, et al. Cardiovascular risk factor profile in subjects with familial predisposition to myocardial infarction in Denmark. J Epidemiol Commun Health. 1997; 51: 266–271.[Abstract]
  23. Margaglione M, Cappucci G, Colaizzo D, et al. C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives. Arterioscler Thromb Vasc Biol. 2000; 20: 198–203.[Abstract/Free Full Text]
  24. Curhan GC, Chertow GM, Willett WC, et al. Birth weight and adult hypertension and obesity in women. Circulation. 1996; 94: 1310–1315.[Abstract/Free Full Text]
  25. Phillips DI. Birth weight and the future development of diabetes: a review of the evidence. Diabetes Care. 1998; 21 (suppl 2): B150–B155.
  26. Yarbrough DE, Barrett-Connor E, Kritz-Silverstein D, et al. Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo Study. Diabetes Care. 1998; 21: 1652–1658.[Abstract]



This article has been cited by other articles:


Home page
Eur Heart JHome page
M. Fischer, B. Mayer, A. Baessler, G. Riegger, J. Erdmann, C. Hengstenberg, and H. Schunkert
Familial aggregation of left main coronary artery disease and future risk of coronary events in asymptomatic siblings of affected patients
Eur. Heart J., October 3, 2007; (2007) ehm377v1.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. I. Parikh, S.-J. Hwang, M. G. Larson, L. A. Cupples, C. S. Fox, E. S. Manders, J. M. Murabito, J. M. Massaro, U. Hoffmann, and C. J. O'Donnell
Parental Occurrence of Premature Cardiovascular Disease Predicts Increased Coronary Artery and Abdominal Aortic Calcification in the Framingham Offspring and Third Generation Cohorts
Circulation, September 25, 2007; 116(13): 1473 - 1481.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al.
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Circulation, June 5, 2007; 115(22): 2878 - 2901.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. M Ridker, J. E. Buring, N. Rifai, and N. R. Cook
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
JAMA, February 14, 2007; 297(6): 611 - 619.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
L. E. Jones and C. P. Carney
Mental Disorders and Revascularization Procedures in a Commercially Insured Sample
Psychosom Med, July 1, 2005; 67(4): 568 - 576.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Mora, L. R. Yanek, T. F. Moy, M. D. Fallin, L. C. Becker, and D. M. Becker
Interaction of Body Mass Index and Framingham Risk Score in Predicting Incident Coronary Disease in Families
Circulation, April 19, 2005; 111(15): 1871 - 1876.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. J. O'Donnell
Family History, Subclinical Atherosclerosis, and Coronary Heart Disease Risk: Barriers and Opportunities for the Use of Family History Information in Risk Prediction and Prevention
Circulation, October 12, 2004; 110(15): 2074 - 2076.
[Full Text] [PDF]


Home page
CirculationHome page
K. Nasir, E. D. Michos, J. A. Rumberger, J. B. Braunstein, W. S. Post, M. J. Budoff, and R. S. Blumenthal
Coronary Artery Calcification and Family History of Premature Coronary Heart Disease: Sibling History Is More Strongly Associated Than Parental History
Circulation, October 12, 2004; 110(15): 2150 - 2156.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. M. Lloyd-Jones, B.-H. Nam, R. B. D'Agostino Sr, D. Levy, J. M. Murabito, T. J. Wang, P. W. F. Wilson, and C. J. O'Donnell
Parental Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-aged Adults: A Prospective Study of Parents and Offspring
JAMA, May 12, 2004; 291(18): 2204 - 2211.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. M. Murabito, B.-H. Nam, R. B. D'Agostino Sr., D. M. Lloyd-Jones, C. J. O'Donnell, and P. W.F. Wilson
Accuracy of Offspring Reports of Parental Cardiovascular Disease History: The Framingham Offspring Study
Ann Intern Med, March 16, 2004; 140(6): 434 - 440.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Flossmann, U. G.R. Schulz, and P. M. Rothwell
Systematic Review of Methods and Results of Studies of the Genetic Epidemiology of Ischemic Stroke
Stroke, January 1, 2004; 35(1): 212 - 227.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. S Parmar
Family history of coronary artery disease -- need to focus on proper definition!
Eur. Heart J., November 2, 2003; 24(22): 2073 - 2073.
[Full Text] [PDF]


Home page
CirculationHome page
T. J. Wang, B.-H. Nam, R. B. D'Agostino, P. A. Wolf, D. M. Lloyd-Jones, C. A. MacRae, P. W. Wilson, J. F. Polak, and C. J. O'Donnell
Carotid Intima-Media Thickness Is Associated With Premature Parental Coronary Heart Disease: The Framingham Heart Study
Circulation, August 5, 2003; 108(5): 572 - 576.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R F Redberg
Are there sex differences in risk factors for coronary heart disease? Maternal versus paternal transmission
Heart, August 1, 2003; 89(8): 817 - 818.
[Full Text] [PDF]


Home page
HeartHome page
S Kinra, G Davey Smith, M Okasha, P McCarron, and J McEwen
Is maternal transmission of coronary heart disease risk stronger than paternal transmission?
Heart, August 1, 2003; 89(8): 834 - 838.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J De Sutter, D De Bacquer, K Kotseva, S Sans, K Pyorala, D Wood, G De Backer, and on behalf of the EUROASPIRE II study group
Screening of family members of patients with premature coronary heart disease: Results from the EUROASPIRE II family survey
Eur. Heart J., February 1, 2003; 24(3): 249 - 257.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V. Stangl, G. Baumann, and K. Stangl
Coronary atherogenic risk factors in women
Eur. Heart J., November 2, 2002; 23(22): 1738 - 1752.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. Simon and H. Rosolova
Family history--and independent risk factors for coronary heart disease, it is time to be practical
Eur. Heart J., November 1, 2002; 23(21): 1637 - 1638.
[Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Increased Cardiovascular Risk with Parental History of MI
Journal Watch Women's Health, September 18, 2001; 2001(918): 2 - 2.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sesso, H. D.
Right arrow Articles by Buring, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sesso, H. D.
Right arrow Articles by Buring, J. E.
Related Collections
Right arrow Epidemiology
Right arrow Cerebrovascular disease/stroke
Right arrow Genetics of cardiovascular disease
Right arrow Primary prevention
Right arrow Risk Factors for Stroke